GUSTO bleeding criteria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
(One intermediate revision by one other user not shown) | |||
Line 8: | Line 8: | ||
{{cquote| | {{cquote| | ||
===1. Severe or | ===1. Severe or Life-threatening:=== | ||
*[[ICH|Intracerebral hemorrhage]] | *[[ICH|Intracerebral hemorrhage]] | ||
*Resulting in substantial hemodynamic compromise requiring treatment | *Resulting in substantial hemodynamic compromise requiring treatment | ||
Line 20: | Line 20: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Medical emergencies]] | [[Category:Medical emergencies]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 21:56, 29 July 2020
Bleeding Microchapters |
Treatment |
---|
Reversal of Anticoagulation and Antiplatelet in Active Bleed |
Perioperative Bleeding |
GUSTO bleeding criteria On the Web |
American Roentgen Ray Society Images of GUSTO bleeding criteria |
Risk calculators and risk factors for GUSTO bleeding criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
GUSTO Bleeding Criteria
Global Utilization Of Streptokinase And Tpa For Occluded Arteries definition for bleeding [1], [2]
“ |
1. Severe or Life-threatening:
2. Moderate:
3. Mild
|
” |
References
- ↑ Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J; et al. (2011). "Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium". Circulation. 123 (23): 2736–47. doi:10.1161/CIRCULATIONAHA.110.009449. PMID 21670242.
- ↑ Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH; et al. (2005). "Association of hemoglobin levels with clinical outcomes in acute coronary syndromes". Circulation. 111 (16): 2042–9. doi:10.1161/01.CIR.0000162477.70955.5F. PMID 15824203.